METHYLPHENIDATE

METHYLPHENIDATE was reported 58050 times

METHYLPHENIDATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADHESIVE TAPE USE 141 0.3672
1 INTENTIONAL REMOVAL OF DRUG DELIVERY SYSTEM BY PATIENT 14 0.2154
2 MYCOBACTERIAL PERITONITIS 19 0.2000
3 DISTURBANCE IN SOCIAL BEHAVIOUR 452 0.1917
4 RESPIRATORY TRACT MALFORMATION 24 0.1805
5 PULMONARY MALFORMATION 57 0.1624
6 MYCOBACTERIUM FORTUITUM INFECTION 22 0.1189
7 EDUCATIONAL PROBLEM 181 0.1088
8 PRODUCT INEFFECTIVE 83 0.1056
9 DERMAL ABSORPTION IMPAIRED 29 0.1036
10 APPLICATION SITE OEDEMA 31 0.0957
11 HIGH RISK SEXUAL BEHAVIOUR 14 0.0773
12 OPPOSITIONAL DEFIANT DISORDER 30 0.0759
13 LUNG CYST 29 0.0738
14 DECREASED EYE CONTACT 22 0.0724
15 INCORRECT STORAGE OF DRUG 118 0.0682
16 APPLICATION SITE BLEEDING 16 0.0648
17 APPLICATION SITE ERYTHEMA 1699 0.0648
18 DRUG ADMINISTERED AT INAPPROPRIATE SITE 680 0.0644
19 CHANGE IN SUSTAINED ATTENTION 19 0.0631
20 APPLICATION SITE URTICARIA 140 0.0623
21 DRUG ADMINISTRATION ERROR 1901 0.0619
22 CHOREOATHETOSIS 40 0.0589
23 OBSESSIVE-COMPULSIVE SYMPTOM 21 0.0569
24 DRUG PRESCRIBING ERROR 1079 0.0561
25 APPLICATION SITE IRRITATION 659 0.0529
26 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1772 0.0487
27 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 19 0.0473
28 APPLICATION SITE EROSION 60 0.0465
29 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 27 0.0462
30 CATAPLEXY 65 0.0459
31 EXPOSURE VIA DIRECT CONTACT 42 0.0442
32 INCORRECT DRUG ADMINISTRATION DURATION 1191 0.0423
33 PRECOCIOUS PUBERTY 24 0.0420
34 LACTATION DISORDER 20 0.0411
35 LIPOPROTEIN (A) INCREASED 13 0.0398
36 DEFIANT BEHAVIOUR 12 0.0390
37 PRODUCT QUALITY ISSUE 5247 0.0386
38 NO ADVERSE EVENT 6896 0.0380
39 POOR SUCKING REFLEX 15 0.0378
40 APPLICATION SITE LACERATION 15 0.0362
41 APPLICATION SITE PRURITUS 812 0.0358
42 NEGATIVISM 27 0.0356
43 IMPULSIVE BEHAVIOUR 133 0.0354
44 TIC 191 0.0350
45 APPLICATION SITE SWELLING 168 0.0337
46 DERMATILLOMANIA 20 0.0336
47 THERAPEUTIC PRODUCT INEFFECTIVE 128 0.0331
48 TRICHOTILLOMANIA 19 0.0324
49 PSYCHOMOTOR HYPERACTIVITY 524 0.0315
50 DRUG EFFECT INCREASED 99 0.0313
51 LOGORRHOEA 104 0.0295
52 KERATOCONUS 11 0.0293
53 APPLICATION SITE DRYNESS 98 0.0288
54 SLEEP-RELATED EATING DISORDER 26 0.0277
55 HYPERKINESIA 58 0.0273
56 APPLICATION SITE DISCOLOURATION 110 0.0270
57 APPLICATION SITE ULCER 19 0.0268
58 PARASOMNIA 19 0.0264
59 SEXUALLY INAPPROPRIATE BEHAVIOUR 12 0.0258
60 DRUG EFFECT DELAYED 114 0.0251
61 PRODUCT ADHESION ISSUE 896 0.0251
62 APPLICATION SITE BRUISE 24 0.0247
63 APPLICATION SITE RASH 337 0.0245
64 SELF-DESTRUCTIVE BEHAVIOUR 21 0.0241
65 HALLUCINATION, TACTILE 16 0.0240
66 DISTRACTIBILITY 27 0.0234
67 ACCIDENTAL EXPOSURE 97 0.0233
68 APPLICATION SITE SCAB 50 0.0231
69 PRE-EXISTING CONDITION IMPROVED 142 0.0227
70 CORONARY ARTERY DISSECTION 19 0.0221
71 ENURESIS 89 0.0220
72 NARCOLEPSY 41 0.0217
73 APPLICATION SITE PAIN 461 0.0209
74 APPLICATION SITE HYPERSENSITIVITY 25 0.0206
75 DEVICE ADHESION ISSUE 304 0.0198
76 MUSCLE CONTRACTURE 40 0.0197
77 PRODUCT ADMINISTRATION ERROR 397 0.0196
78 PRESCRIPTION FORM TAMPERING 15 0.0195
79 APPLICATION SITE DISCOMFORT 34 0.0189
80 PRODUCT ADMINISTRATION INTERRUPTED 144 0.0183
81 APPLICATION SITE INFLAMMATION 25 0.0181
82 DISSOCIATIVE DISORDER 13 0.0180
83 ATTENTION DEFICIT HYPERACTIVITY DISORDER 73 0.0173
84 DISTURBANCE IN ATTENTION 916 0.0170
85 URTICARIA GENERALISED 11 0.0169
86 APPLICATION SITE BURN 82 0.0166
87 OROMANDIBULAR DYSTONIA 12 0.0165
88 APPLICATION SITE WARMTH 21 0.0165
89 STEREOTYPY 15 0.0159
90 APPLICATION SITE VESICLES 103 0.0159
91 APPLICATION SITE EXFOLIATION 64 0.0155
92 EXCESSIVE EYE BLINKING 22 0.0149
93 ABNORMAL SLEEP-RELATED EVENT 19 0.0144
94 APPLICATION SITE DERMATITIS 13 0.0139
95 MATERNAL EXPOSURE DURING BREAST FEEDING 55 0.0135
96 SUBSTANCE USE DISORDER 41 0.0129
97 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 25 0.0127
98 OBSTRUCTIVE SLEEP APNOEA SYNDROME 18 0.0123
99 AGGRESSION 600 0.0120
100 INTRUSIVE THOUGHTS 14 0.0119
101 REDUCED FACIAL EXPRESSION 12 0.0118
102 ABNORMAL BEHAVIOUR 463 0.0117
103 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 26 0.0116
104 SLEEP PARALYSIS 17 0.0116
105 KOUNIS SYNDROME 26 0.0114
106 PRESCRIBED OVERDOSE 221 0.0114
107 APPLICATION SITE PAPULES 12 0.0113
108 GROWTH RETARDATION 33 0.0112
109 CARDIAC VALVE DISEASE 64 0.0112
110 THERAPEUTIC PRODUCT EFFECT INCREASED 13 0.0112
111 EXPOSURE VIA BREAST MILK 44 0.0110
112 SOMNAMBULISM 72 0.0110
113 SPLENIC INFARCTION 19 0.0109
114 SLEEP APNOEA SYNDROME 207 0.0108
115 VITILIGO 24 0.0102
116 SLEEP TALKING 17 0.0100
117 SEDATION COMPLICATION 25 0.0098
118 BEZOAR 13 0.0094
119 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 172 0.0094
120 HOMICIDAL IDEATION 38 0.0094
121 WISDOM TEETH REMOVAL 12 0.0091
122 SUBSTANCE USE 14 0.0090
123 MECHANICAL VENTILATION 17 0.0089
124 DRUG DOSE OMISSION 1478 0.0089
125 SUICIDAL BEHAVIOUR 37 0.0089
126 CHOREA 15 0.0087
127 DRUG TOLERANCE 44 0.0087
128 CHRONIC FATIGUE SYNDROME 12 0.0086
129 INITIAL INSOMNIA 87 0.0085
130 TRISMUS 43 0.0083
131 MUTISM 12 0.0083
132 SNORING 31 0.0082
133 AFFECT LABILITY 78 0.0081
134 ARTERIOSCLEROSIS CORONARY ARTERY 53 0.0080
135 EXPIRED DRUG ADMINISTERED 39 0.0079
136 BRUXISM 42 0.0078
137 DAYDREAMING 12 0.0078
138 GLUTEN SENSITIVITY 11 0.0077
139 POISONING 96 0.0076
140 SEROTONIN SYNDROME 146 0.0076
141 PRODUCT SUBSTITUTION ISSUE 437 0.0076
142 INCORRECT DOSE ADMINISTERED BY PRODUCT 12 0.0075
143 ENDOTRACHEAL INTUBATION 21 0.0075
144 PRE-ECLAMPSIA 35 0.0074
145 OBSESSIVE-COMPULSIVE DISORDER 59 0.0073
146 TERMINAL INSOMNIA 13 0.0073
147 APPLICATION SITE HAEMORRHAGE 20 0.0073
148 DRUG DIVERSION 45 0.0073
149 MYDRIASIS 93 0.0072
150 MITRAL VALVE PROLAPSE 12 0.0072
151 BEHAVIOUR DISORDER 39 0.0072
152 APPLICATION SITE REACTION 50 0.0071
153 OCULOGYRIC CRISIS 15 0.0070
154 THERAPEUTIC PRODUCT EFFECT VARIABLE 27 0.0070
155 SCREAMING 44 0.0069
156 PERSECUTORY DELUSION 17 0.0068
157 OFF LABEL USE 5959 0.0068
158 IMPULSE-CONTROL DISORDER 14 0.0068
159 TONGUE BITING 14 0.0068
160 AUTISM SPECTRUM DISORDER 37 0.0067
161 PRIAPISM 23 0.0067
162 DRUG USE DISORDER 56 0.0067
163 STARING 16 0.0066
164 TORTICOLLIS 14 0.0066
165 ANGER 222 0.0066
166 HANGOVER 23 0.0065
167 DEVICE BREAKAGE 263 0.0065
168 SKIN WOUND 11 0.0065
169 ACUTE PSYCHOSIS 16 0.0065
170 AGITATION 463 0.0063
171 DEVICE DIFFICULT TO USE 415 0.0063
172 IRRITABILITY 376 0.0062
173 HYPERTONIC BLADDER 18 0.0062
174 PHYSICAL ASSAULT 13 0.0062
175 INCREASED APPETITE 118 0.0062
176 SLEEP DEFICIT 13 0.0061
177 PARANOIA 106 0.0061
178 NASAL SEPTUM DEVIATION 12 0.0061
179 DYSTONIA 115 0.0059
180 INTRACRANIAL PRESSURE INCREASED 33 0.0059
181 SOCIAL AVOIDANT BEHAVIOUR 34 0.0059
182 SUSPECTED SUICIDE 27 0.0058
183 MAJOR DEPRESSION 42 0.0057
184 LIVEDO RETICULARIS 12 0.0057
185 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1157 0.0057
186 HALLUCINATION, VISUAL 118 0.0056
187 DRUG DELIVERY SYSTEM ISSUE 11 0.0056
188 HOSTILITY 14 0.0055
189 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 28 0.0055
190 RADIUS FRACTURE 13 0.0054
191 INSULIN RESISTANCE 11 0.0053
192 SUBSTANCE ABUSE 43 0.0053
193 ARTERIOSPASM CORONARY 21 0.0052
194 CRYING 190 0.0052
195 INTENTIONAL SELF-INJURY 104 0.0051
196 DYSKINESIA 209 0.0051
197 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15 0.0051
198 POST-TRAUMATIC STRESS DISORDER 34 0.0051
199 DRUG ABUSE 420 0.0050
200 HYPERPHAGIA 20 0.0050
201 PSYCHOTIC DISORDER 148 0.0050
202 COMMUNICATION DISORDER 19 0.0050
203 DISSOCIATION 38 0.0050
204 DERMATITIS CONTACT 56 0.0049
205 NYSTAGMUS 26 0.0049
206 THERAPEUTIC RESPONSE CHANGED 31 0.0049
207 INCORRECT PRODUCT STORAGE 64 0.0049
208 BLOOD PRESSURE SYSTOLIC ABNORMAL 12 0.0049
209 GAMBLING DISORDER 13 0.0048
210 SUICIDAL IDEATION 440 0.0048
211 MANIA 79 0.0048
212 APATHY 70 0.0048
213 THERAPY CESSATION 246 0.0048
214 SELF-INJURIOUS IDEATION 20 0.0048
215 BRADYPHRENIA 31 0.0047
216 HALLUCINATION, AUDITORY 75 0.0047
217 BLOOD PRESSURE DIASTOLIC ABNORMAL 12 0.0047
218 FEELING DRUNK 35 0.0047
219 HYPOMANIA 17 0.0046
220 TACHYPHRENIA 16 0.0046
221 THERAPEUTIC PRODUCT EFFECT DELAYED 21 0.0046
222 HALLUCINATIONS, MIXED 19 0.0045
223 DRUG EFFECT DECREASED 243 0.0045
224 CLUMSINESS 12 0.0044
225 CATATONIA 23 0.0044
226 AFFECTIVE DISORDER 34 0.0043
227 RESTLESSNESS 158 0.0043
228 SEDATION 111 0.0042
229 LYME DISEASE 14 0.0042
230 PANIC ATTACK 153 0.0042
231 FEELING JITTERY 79 0.0041
232 THERAPEUTIC RESPONSE UNEXPECTED 185 0.0041
233 AKATHISIA 56 0.0041
234 EUPHORIC MOOD 42 0.0041
235 TOXICITY TO VARIOUS AGENTS 691 0.0041
236 PRODUCT FORMULATION ISSUE 27 0.0041
237 BRADYPNOEA 11 0.0041
238 DELUSION 63 0.0041
239 DEPRESSED MOOD 213 0.0040
240 HYPERREFLEXIA 14 0.0040
241 MOOD SWINGS 128 0.0040
242 EMOTIONAL DISORDER 123 0.0040
243 DEPRESSIVE SYMPTOM 14 0.0040
244 HUNGER 54 0.0039
245 BIPOLAR DISORDER 42 0.0039
246 HYPERPROLACTINAEMIA 25 0.0039
247 TACHYCARDIA 342 0.0038
248 CONGESTIVE CARDIOMYOPATHY 16 0.0038
249 SEASONAL ALLERGY 54 0.0038
250 PARADOXICAL DRUG REACTION 14 0.0038
251 COMA SCALE ABNORMAL 11 0.0038
252 STRESS CARDIOMYOPATHY 22 0.0038
253 WITHDRAWAL SYNDROME 158 0.0038
254 HYPERACUSIS 14 0.0038
255 RESTLESS LEGS SYNDROME 68 0.0037
256 TEARFULNESS 16 0.0037
257 BLOOD SODIUM INCREASED 10 0.0037
258 INTENTIONAL OVERDOSE 235 0.0037
259 DRUG EFFECT LESS THAN EXPECTED 54 0.0036
260 MOOD ALTERED 99 0.0036
261 DECREASED INTEREST 21 0.0036
262 PERSONALITY CHANGE 33 0.0035
263 PETIT MAL EPILEPSY 18 0.0035
264 SUICIDE ATTEMPT 213 0.0035
265 DECREASED APPETITE 815 0.0035
266 SALIVARY HYPERSECRETION 35 0.0035
267 PANIC REACTION 25 0.0035
268 MITRAL VALVE INCOMPETENCE 39 0.0034
269 DYSPHEMIA 15 0.0034
270 COMPLETED SUICIDE 285 0.0034
271 EYE MOVEMENT DISORDER 23 0.0034
272 PRODUCT RESIDUE PRESENT 18 0.0033
273 PRODUCT AVAILABILITY ISSUE 76 0.0033
274 SLEEP TERROR 14 0.0033
275 TREATMENT NONCOMPLIANCE 181 0.0033
276 CRANIOCEREBRAL INJURY 10 0.0033
277 MUSCLE TWITCHING 75 0.0033
278 BRAIN DEATH 10 0.0032
279 UNRESPONSIVE TO STIMULI 83 0.0032
280 DRUG LEVEL INCREASED 53 0.0032
281 STATUS EPILEPTICUS 36 0.0032
282 BODY TEMPERATURE INCREASED 65 0.0032
283 AUTOIMMUNE THYROIDITIS 12 0.0032
284 DYSPHORIA 16 0.0032
285 HYPERTHERMIA 24 0.0031
286 HYPERTONIA 18 0.0031
287 SURGERY 184 0.0031
288 DEVICE PHYSICAL PROPERTY ISSUE 24 0.0031
289 MUSCLE CONTRACTIONS INVOLUNTARY 11 0.0031
290 CONCUSSION 24 0.0031
291 SINUS TACHYCARDIA 44 0.0031
292 STREPTOCOCCAL INFECTION 17 0.0031
293 MYOCARDITIS 35 0.0031
294 ANXIETY 868 0.0030
295 BUNDLE BRANCH BLOCK RIGHT 14 0.0030
296 SHOULDER OPERATION 13 0.0030
297 GENERALISED TONIC-CLONIC SEIZURE 50 0.0030
298 APPETITE DISORDER 20 0.0030
299 TACHYPNOEA 41 0.0030
300 REBOUND EFFECT 34 0.0030
301 FOOD ALLERGY 23 0.0030
302 ELECTROCARDIOGRAM QT PROLONGED 107 0.0030
303 VITAMIN B12 DEFICIENCY 12 0.0030
304 RESPIRATORY DEPRESSION 36 0.0029
305 INCOHERENT 19 0.0029
306 ABNORMAL LOSS OF WEIGHT 20 0.0029
307 ANAL INCONTINENCE 26 0.0029
308 VITAMIN D DEFICIENCY 28 0.0029
309 SOMNOLENCE 574 0.0028
310 BRAIN OEDEMA 36 0.0028
311 DEPRESSION 641 0.0028
312 BLOOD PRESSURE DIASTOLIC INCREASED 13 0.0028
313 INSOMNIA 746 0.0028
314 OVERWEIGHT 15 0.0028
315 PERFORMANCE STATUS DECREASED 13 0.0028
316 CARDIO-RESPIRATORY ARREST 115 0.0027
317 MIDDLE INSOMNIA 51 0.0027
318 FORMICATION 19 0.0027
319 RECALLED PRODUCT ADMINISTERED 26 0.0027
320 IRON DEFICIENCY 12 0.0027
321 DRUG SCREEN POSITIVE 21 0.0027
322 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 11 0.0026
323 POOR QUALITY SLEEP 57 0.0026
324 URINARY INCONTINENCE 78 0.0026
325 INTENTIONAL DOSE OMISSION 74 0.0026
326 HYPERVENTILATION 15 0.0026
327 FOOT FRACTURE 49 0.0026
328 COORDINATION ABNORMAL 36 0.0026
329 ROSACEA 12 0.0026
330 HALLUCINATION 194 0.0026
331 APNOEA 20 0.0026
332 SLEEP DISORDER 181 0.0026
333 SLUGGISHNESS 26 0.0025
334 ENDOMETRIOSIS 12 0.0025
335 OBESITY 40 0.0025
336 DRUG INTERACTION 397 0.0025
337 THERAPY PARTIAL RESPONDER 39 0.0025
338 THIRST 44 0.0025
339 ANKLE FRACTURE 38 0.0025
340 HYSTERECTOMY 21 0.0024
341 ELECTROCARDIOGRAM ABNORMAL 19 0.0024
342 DEVICE ISSUE 217 0.0024
343 MULTIPLE DRUG OVERDOSE 12 0.0024
344 METABOLIC DISORDER 14 0.0024
345 NIGHTMARE 83 0.0024
346 NOCTURIA 29 0.0024
347 GRAND MAL CONVULSION 22 0.0024
348 INTENTIONAL PRODUCT MISUSE 208 0.0024
349 NEUROLEPTIC MALIGNANT SYNDROME 28 0.0024
350 HYPOKINESIA 34 0.0023
351 SKIN ABRASION 11 0.0023
352 INTENTIONAL PRODUCT USE ISSUE 202 0.0023
353 PARTIAL SEIZURES 12 0.0023
354 ATAXIA 27 0.0023
355 DRUG LEVEL DECREASED 23 0.0023
356 COELIAC DISEASE 22 0.0022
357 KNEE OPERATION 22 0.0022
358 FRUSTRATION TOLERANCE DECREASED 18 0.0022
359 INSURANCE ISSUE 34 0.0022
360 BLEPHAROSPASM 14 0.0022
361 DRUG INEFFECTIVE 2929 0.0022
362 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 12 0.0022
363 IMPAIRED GASTRIC EMPTYING 30 0.0022
364 THINKING ABNORMAL 41 0.0022
365 HYPERAMMONAEMIA 11 0.0022
366 IMPAIRED DRIVING ABILITY 25 0.0022
367 PSYCHIATRIC SYMPTOM 16 0.0022
368 TARDIVE DYSKINESIA 61 0.0022
369 MENTAL IMPAIRMENT 52 0.0021
370 FEELING OF DESPAIR 10 0.0021
371 EXTRAPYRAMIDAL DISORDER 53 0.0021
372 APLASTIC ANAEMIA 11 0.0021
373 MIGRAINE 201 0.0021
374 BRAIN FOG 33 0.0021
375 LETHARGY 121 0.0021
376 HYPERHIDROSIS 270 0.0021
377 HYPERSOMNIA 60 0.0021
378 MUSCLE RIGIDITY 25 0.0021
379 IMPAIRED QUALITY OF LIFE 30 0.0021
380 OVERDOSE 447 0.0021
381 MOTOR DYSFUNCTION 21 0.0021
382 ECCHYMOSIS 14 0.0020
383 ENERGY INCREASED 12 0.0020
384 RESPIRATION ABNORMAL 14 0.0020
385 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
386 BACK INJURY 22 0.0020
387 MENTAL DISORDER 88 0.0020
388 FOOT OPERATION 10 0.0020
389 CHOLECYSTECTOMY 23 0.0020
390 DEPRESSED LEVEL OF CONSCIOUSNESS 79 0.0020
391 MIOSIS 16 0.0020
392 THERAPEUTIC PRODUCT EFFECT DECREASED 89 0.0020
393 CYSTIC FIBROSIS 11 0.0020
394 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
395 FIBROMYALGIA 48 0.0020
396 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12 0.0020
397 PRODUCT SUPPLY ISSUE 14 0.0020
398 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0020
399 CARDIAC FAILURE ACUTE 13 0.0019
400 HYPOTHYROIDISM 62 0.0019
401 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
402 SCOLIOSIS 12 0.0019
403 THERAPEUTIC RESPONSE SHORTENED 64 0.0019
404 TOOTH EXTRACTION 24 0.0019
405 LIGAMENT SPRAIN 19 0.0019
406 FOOD CRAVING 10 0.0019
407 HYPERTENSION 402 0.0019
408 NERVOUSNESS 99 0.0019
409 TREMOR 314 0.0019
410 HEAVY MENSTRUAL BLEEDING 17 0.0019
411 CIRCULATORY COLLAPSE 32 0.0019
412 EATING DISORDER 40 0.0019
413 ACCIDENTAL EXPOSURE TO PRODUCT 193 0.0019
414 GALACTORRHOEA 12 0.0019
415 SPINAL OPERATION 23 0.0019
416 FEAR 50 0.0019
417 ABNORMAL DREAMS 51 0.0018
418 SKIN REACTION 26 0.0018
419 PNEUMONIA ASPIRATION 46 0.0018
420 BLOOD CREATINE PHOSPHOKINASE INCREASED 53 0.0018
421 WEIGHT DECREASED 513 0.0018
422 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
423 PRODUCT PHYSICAL ISSUE 37 0.0018
424 CONDITION AGGRAVATED 557 0.0018
425 PALPITATIONS 214 0.0018
426 PERIPHERAL COLDNESS 25 0.0018
427 DISABILITY 36 0.0018
428 SCHIZOPHRENIA 22 0.0018
429 DENTAL CARIES 20 0.0018
430 FEELING ABNORMAL 432 0.0018
431 INCONTINENCE 19 0.0018
432 INTERVERTEBRAL DISC PROTRUSION 39 0.0018
433 UTERINE LEIOMYOMA 13 0.0018
434 PRODUCT USE COMPLAINT 28 0.0018
435 HEART RATE INCREASED 175 0.0018
436 PRODUCT PRESCRIBING ERROR 42 0.0018
437 LARGE INTESTINE POLYP 12 0.0017
438 HEPATIC STEATOSIS 32 0.0017
439 SEIZURE 198 0.0017
440 COGNITIVE DISORDER 80 0.0017
441 CLOSTRIDIUM DIFFICILE COLITIS 18 0.0017
442 MEMORY IMPAIRMENT 233 0.0017
443 BRAIN INJURY 17 0.0017
444 ORAL HERPES 33 0.0017
445 RESPIRATORY RATE INCREASED 15 0.0017
446 GYNAECOMASTIA 52 0.0017
447 MYOCLONUS 20 0.0017
448 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 119 0.0017
449 UNEVALUABLE EVENT 126 0.0017
450 MULTIPLE ALLERGIES 13 0.0017
451 SPEECH DISORDER 86 0.0016
452 NEPHROLITHIASIS 75 0.0016
453 RESPIRATORY ARREST 45 0.0016
454 SENSORY DISTURBANCE 26 0.0016
455 SCRATCH 17 0.0016
456 JOINT DISLOCATION 17 0.0016
457 ORTHOSTATIC HYPOTENSION 28 0.0016
458 MUSCLE TIGHTNESS 26 0.0016
459 FOETAL EXPOSURE DURING PREGNANCY 130 0.0016
460 RETCHING 34 0.0016
461 CYANOSIS 25 0.0016
462 NIGHT SWEATS 51 0.0016
463 MICTURITION URGENCY 18 0.0016
464 DECREASED ACTIVITY 17 0.0016
465 GASTROOESOPHAGEAL REFLUX DISEASE 126 0.0016
466 NEURALGIA 38 0.0016
467 LOSS OF LIBIDO 14 0.0016
468 DRY MOUTH 125 0.0015
469 DRUG-INDUCED LIVER INJURY 48 0.0015
470 CONFUSIONAL STATE 247 0.0015
471 INCORRECT PRODUCT ADMINISTRATION DURATION 33 0.0015
472 AMNESIA 99 0.0015
473 VITAMIN D DECREASED 13 0.0015
474 PHOTOSENSITIVITY REACTION 25 0.0015
475 SUDDEN DEATH 16 0.0015
476 BLADDER DISORDER 15 0.0015
477 INABILITY TO AFFORD MEDICATION 15 0.0015
478 PHARMACEUTICAL PRODUCT COMPLAINT 39 0.0015
479 BLOOD PRESSURE INCREASED 229 0.0015
480 ACUTE MYOCARDIAL INFARCTION 44 0.0015
481 BREAST MASS 10 0.0015
482 LYMPHOPENIA 21 0.0015
483 INTENTIONAL DRUG MISUSE 31 0.0015
484 MENTAL STATUS CHANGES 41 0.0015
485 POST PROCEDURAL INFECTION 12 0.0015
486 WEIGHT INCREASED 330 0.0015
487 LIMB INJURY 40 0.0015
488 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 25 0.0015
489 RASH GENERALISED 38 0.0015
490 MUSCULOSKELETAL DISCOMFORT 25 0.0015
491 SINUS BRADYCARDIA 14 0.0014
492 SINUSITIS 148 0.0014
493 STEVENS-JOHNSON SYNDROME 32 0.0014
494 AUTOIMMUNE DISORDER 14 0.0014
495 MALNUTRITION 16 0.0014
496 SKIN IRRITATION 65 0.0014
497 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 68 0.0014
498 LOSS OF CONSCIOUSNESS 181 0.0014
499 NERVE COMPRESSION 13 0.0014
500 MOVEMENT DISORDER 45 0.0014
501 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24 0.0014
502 CARDIAC ARREST 115 0.0014
503 TREATMENT FAILURE 115 0.0014
504 GASTROENTERITIS VIRAL 25 0.0014
505 MUSCLE SPASTICITY 17 0.0014
506 SKIN LACERATION 15 0.0014
507 PRODUCT DISPENSING ERROR 30 0.0014
508 DRY THROAT 14 0.0014
509 EXPOSURE DURING PREGNANCY 85 0.0014
510 SEXUAL DYSFUNCTION 16 0.0014
511 ERECTILE DYSFUNCTION 35 0.0014
512 ROAD TRAFFIC ACCIDENT 57 0.0014
513 TOOTH FRACTURE 15 0.0014
514 PRODUCT COMMUNICATION ISSUE 12 0.0014
515 THERAPY NON-RESPONDER 61 0.0014
516 IMPAIRED WORK ABILITY 29 0.0014
517 EXPIRED PRODUCT ADMINISTERED 45 0.0014
518 POOR VENOUS ACCESS 14 0.0014
519 ARTHROPOD BITE 10 0.0013
520 HEADACHE 846 0.0013
521 NERVE INJURY 15 0.0013
522 ASPHYXIA 11 0.0013
523 COMA 64 0.0013
524 HYPERAESTHESIA 11 0.0013
525 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 73 0.0013
526 PHARYNGEAL SWELLING 13 0.0013
527 THERAPY CHANGE 13 0.0013
528 LIP DRY 12 0.0013
529 THERAPEUTIC RESPONSE DECREASED 80 0.0013
530 URINARY RETENTION 44 0.0013
531 EAR INFECTION 35 0.0013
532 EXOSTOSIS 12 0.0013
533 ATRIAL SEPTAL DEFECT 11 0.0013
534 DISORIENTATION 52 0.0013
535 SENSATION OF FOREIGN BODY 11 0.0013
536 HEAD DISCOMFORT 23 0.0013
537 BACK DISORDER 21 0.0013
538 FACIAL PARALYSIS 11 0.0013
539 PALLOR 35 0.0013
540 APPENDICITIS 12 0.0013
541 FEEDING DISORDER 26 0.0013
542 EPILEPSY 39 0.0013
543 PSYCHOLOGICAL TRAUMA 11 0.0013
544 DELIRIUM 44 0.0013
545 QUALITY OF LIFE DECREASED 17 0.0013
546 BLOOD IRON DECREASED 15 0.0013
547 RIB FRACTURE 26 0.0013
548 ILLNESS 130 0.0013
549 APHASIA 38 0.0013
550 SINUS CONGESTION 17 0.0013
551 BLOOD PRESSURE ABNORMAL 25 0.0013
552 MULTIPLE SCLEROSIS RELAPSE 86 0.0013
553 SCIATICA 20 0.0013
554 CARDIOGENIC SHOCK 18 0.0013
555 SPINAL OSTEOARTHRITIS 11 0.0013
556 POLLAKIURIA 52 0.0012
557 ROTATOR CUFF SYNDROME 16 0.0012
558 LYMPHOCYTE COUNT DECREASED 22 0.0012
559 PRODUCT DOSE OMISSION 81 0.0012
560 DEVICE MECHANICAL ISSUE 17 0.0012
561 KIDNEY INFECTION 24 0.0012
562 RHABDOMYOLYSIS 51 0.0012
563 EYE DISORDER 40 0.0012
564 ABNORMAL WEIGHT GAIN 15 0.0012
565 TOOTH DISORDER 27 0.0012
566 CARPAL TUNNEL SYNDROME 17 0.0012
567 PULMONARY CONGESTION 16 0.0012
568 IRRITABLE BOWEL SYNDROME 26 0.0012
569 ACTIVITIES OF DAILY LIVING IMPAIRED 24 0.0012
570 DEVICE DEFECTIVE 21 0.0012
571 SARS-COV-2 TEST POSITIVE 16 0.0012
572 CYST 15 0.0012
573 DRUG RESISTANCE 31 0.0012
574 ARRHYTHMIA 57 0.0012
575 DRUG WITHDRAWAL SYNDROME 105 0.0012
576 BALANCE DISORDER 103 0.0012
577 BRONCHOSPASM 17 0.0012
578 ECONOMIC PROBLEM 18 0.0012
579 ASPIRATION 13 0.0012
580 HEPATIC ENCEPHALOPATHY 11 0.0012
581 DRUG DISPENSING ERROR 18 0.0012
582 TINNITUS 54 0.0012
583 NEUTROPHIL COUNT INCREASED 12 0.0012
584 CONVULSION 67 0.0012
585 ACUTE HEPATIC FAILURE 16 0.0012
586 PHOTOPHOBIA 22 0.0012
587 DEVICE RELATED INFECTION 18 0.0012
588 EAR DISCOMFORT 12 0.0012
589 THYROID DISORDER 18 0.0012
590 CENTRAL NERVOUS SYSTEM LESION 16 0.0012
591 BLOOD POTASSIUM DECREASED 35 0.0012
592 DISCOMFORT 71 0.0012
593 SINUS DISORDER 23 0.0012
594 POISONING DELIBERATE 11 0.0012
595 PRODUCT PACKAGING ISSUE 11 0.0012
596 ABDOMINAL PAIN UPPER 238 0.0012
597 VENTRICULAR EXTRASYSTOLES 12 0.0012
598 VENTRICULAR TACHYCARDIA 19 0.0011
599 BRADYCARDIA 61 0.0011
600 PETECHIAE 12 0.0011
601 SKIN HAEMORRHAGE 17 0.0011
602 THROAT TIGHTNESS 31 0.0011
603 PRODUCT ODOUR ABNORMAL 12 0.0011
604 DRY EYE 57 0.0011
605 KNEE ARTHROPLASTY 24 0.0011
606 TOOTH INFECTION 15 0.0011
607 HYPOPHAGIA 29 0.0011
608 VOMITING 530 0.0011
609 RESPIRATORY DISTRESS 31 0.0011
610 HEPATOMEGALY 11 0.0011
611 MUSCLE SPASMS 205 0.0011
612 FATIGUE 866 0.0011
613 SCAR 19 0.0011
614 MULTIPLE SCLEROSIS 53 0.0011
615 DRUG DEPENDENCE 178 0.0011
616 HEAD INJURY 35 0.0011
617 GASTROINTESTINAL DISORDER 99 0.0011
618 ANHEDONIA 29 0.0011
619 HYPERSENSITIVITY 204 0.0011
620 PRODUCT DOSE OMISSION ISSUE 323 0.0011
621 MEDICATION ERROR 61 0.0011
622 POOR QUALITY DEVICE USED 11 0.0011
623 DIZZINESS 546 0.0011
624 CHOLESTASIS 21 0.0011
625 PERITONITIS BACTERIAL 11 0.0011
626 CONTRAINDICATED PRODUCT ADMINISTERED 33 0.0011
627 DYSARTHRIA 41 0.0011
628 VENTRICULAR FIBRILLATION 12 0.0011
629 DIPLOPIA 28 0.0011
630 VISION BLURRED 148 0.0011
631 DRUG INTOLERANCE 104 0.0011
632 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
633 PANCREATITIS ACUTE 24 0.0011
634 FLANK PAIN 10 0.0011
635 PRURITUS GENERALISED 23 0.0011
636 METABOLIC ACIDOSIS 34 0.0011
637 NECK PAIN 59 0.0011
638 FALL 351 0.0011
639 NAUSEA 832 0.0011
640 PULMONARY OEDEMA 47 0.0010
641 HYPOAESTHESIA 157 0.0010
642 MUSCULAR WEAKNESS 119 0.0010
643 WHITE BLOOD CELL COUNT INCREASED 40 0.0010
644 PARAESTHESIA 164 0.0010
645 LOWER LIMB FRACTURE 20 0.0010
646 TENDONITIS 16 0.0010
647 DIZZINESS POSTURAL 10 0.0010
648 BLOOD CHOLESTEROL INCREASED 48 0.0010
649 DEVICE USE ISSUE 18 0.0010
650 FEELING HOT 63 0.0010
651 HYPOXIA 36 0.0010
652 ABDOMINAL DISCOMFORT 170 0.0010
653 GAIT DISTURBANCE 193 0.0010
654 IMMUNODEFICIENCY 15 0.0010
655 FEELING COLD 28 0.0010
656 ACCIDENT 12 0.0010
657 HIATUS HERNIA 13 0.0010
658 APHONIA 14 0.0010
659 RESPIRATORY DISORDER 30 0.0010
660 DEAFNESS 26 0.0010
661 ECZEMA 52 0.0010
662 FOOT DEFORMITY 11 0.0010
663 CHEST PAIN 183 0.0010
664 END STAGE RENAL DISEASE 18 0.0010
665 BRONCHITIS 73 0.0010
666 OCULAR DISCOMFORT 11 0.0010
667 FLUSHING 99 0.0010
668 HEART RATE DECREASED 34 0.0010
669 NASOPHARYNGITIS 178 0.0010
670 PRODUCT PRESCRIBING ISSUE 21 0.0010
671 PRODUCT TASTE ABNORMAL 13 0.0010
672 GASTROENTERITIS 14 0.0010
673 GAIT INABILITY 32 0.0010
674 PRODUCT DOSE OMISSION IN ERROR 27 0.0010
675 PRODUCT USE ISSUE 179 0.0010
676 ELECTROLYTE IMBALANCE 11 0.0009
677 LEUKOCYTOSIS 17 0.0009
678 GLOSSODYNIA 21 0.0009
679 ORAL PAIN 21 0.0009
680 ASTHMA 106 0.0009
681 CHRONIC KIDNEY DISEASE 71 0.0009
682 INFUSION SITE PAIN 12 0.0009
683 HYPOAESTHESIA ORAL 14 0.0009
684 HEPATIC ENZYME INCREASED 63 0.0009
685 CHOKING 18 0.0009
686 OSTEOPENIA 14 0.0009
687 HYPERLIPIDAEMIA 11 0.0009
688 OSTEOARTHRITIS 39 0.0009
689 VERTIGO 56 0.0009
690 LIMB DISCOMFORT 28 0.0009
691 PRESYNCOPE 22 0.0009
692 MUSCULOSKELETAL CHEST PAIN 14 0.0009
693 UPPER LIMB FRACTURE 18 0.0009
694 GASTRIC DISORDER 31 0.0009
695 NO THERAPEUTIC RESPONSE 11 0.0009
696 ACCIDENTAL OVERDOSE 33 0.0009
697 SWOLLEN TONGUE 28 0.0009
698 DERMATITIS ATOPIC 47 0.0009
699 NASAL CONGESTION 52 0.0009
700 DYSPEPSIA 87 0.0009
701 TOOTHACHE 16 0.0009
702 URTICARIA 148 0.0009
703 ADVERSE DRUG REACTION 79 0.0009
704 HERNIA 17 0.0009
705 INCORRECT DOSE ADMINISTERED 200 0.0009
706 VIRAL INFECTION 29 0.0009
707 INCORRECT ROUTE OF DRUG ADMINISTRATION 31 0.0009
708 DISEASE RECURRENCE 41 0.0009
709 CAESAREAN SECTION 10 0.0009
710 BACTERIAL INFECTION 16 0.0009
711 UPPER RESPIRATORY TRACT INFECTION 39 0.0008
712 JOINT INJURY 18 0.0008
713 LIP SWELLING 28 0.0008
714 CATARACT 50 0.0008
715 COVID-19 147 0.0008
716 ANGINA PECTORIS 24 0.0008
717 BLOOD UREA INCREASED 14 0.0008
718 BLOOD PRESSURE FLUCTUATION 20 0.0008
719 CONSTIPATION 181 0.0008
720 DYSMENORRHOEA 11 0.0008
721 ASPARTATE AMINOTRANSFERASE INCREASED 44 0.0008
722 SKIN DISCOLOURATION 38 0.0008
723 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
724 BURSITIS 10 0.0008
725 ADRENAL INSUFFICIENCY 10 0.0008
726 MALIGNANT MELANOMA 11 0.0008
727 RASH 356 0.0008
728 MALAISE 358 0.0008
729 PULMONARY HYPERTENSION 17 0.0008
730 ABSCESS 13 0.0008
731 DERMATITIS 17 0.0008
732 DYSPHAGIA 77 0.0008
733 SNEEZING 18 0.0008
734 THROAT IRRITATION 36 0.0008
735 VISUAL IMPAIRMENT 99 0.0008
736 AMENORRHOEA 14 0.0008
737 DERMATITIS ALLERGIC 10 0.0008
738 COLD SWEAT 14 0.0008
739 SYNCOPE 79 0.0008
740 INFLUENZA 88 0.0008
741 ALANINE AMINOTRANSFERASE INCREASED 48 0.0008
742 CONTUSION 75 0.0008
743 PRODUCT PREPARATION ERROR 16 0.0008
744 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 55 0.0008
745 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
746 HAEMORRHOIDS 15 0.0008
747 NERVOUS SYSTEM DISORDER 24 0.0008
748 ANGIOEDEMA 34 0.0008
749 PARALYSIS 11 0.0008
750 PRURITUS 293 0.0008
751 LACRIMATION INCREASED 23 0.0008
752 ANAPHYLACTIC REACTION 42 0.0008
753 RHINORRHOEA 49 0.0008
754 RASH ERYTHEMATOUS 36 0.0008
755 HEART RATE IRREGULAR 17 0.0008
756 SKIN DISORDER 25 0.0007
757 HAEMATEMESIS 19 0.0007
758 OROPHARYNGEAL PAIN 69 0.0007
759 CHEST DISCOMFORT 76 0.0007
760 NEUROPATHY PERIPHERAL 70 0.0007
761 EMOTIONAL DISTRESS 89 0.0007
762 DEHYDRATION 98 0.0007
763 CORONARY ARTERY OCCLUSION 10 0.0007
764 SKIN LESION 20 0.0007
765 POST PROCEDURAL COMPLICATION 14 0.0007
766 ACUTE RESPIRATORY FAILURE 14 0.0007
767 STAPHYLOCOCCAL INFECTION 24 0.0007
768 FLUID RETENTION 37 0.0007
769 GLAUCOMA 14 0.0007
770 URINARY TRACT INFECTION 124 0.0007
771 GASTRITIS 19 0.0007
772 DYSSTASIA 21 0.0007
773 DYSPHONIA 42 0.0007
774 ASTHENIA 270 0.0007
775 OSTEOMYELITIS 13 0.0007
776 OCULAR HYPERAEMIA 34 0.0007
777 SKIN FISSURES 14 0.0007
778 DRUG EFFECT INCOMPLETE 26 0.0007
779 CELLULITIS 36 0.0007
780 PERICARDITIS 12 0.0007
781 TYPE 2 DIABETES MELLITUS 24 0.0007
782 HYPOTENSION 143 0.0007
783 CANDIDA INFECTION 12 0.0007
784 LACTIC ACIDOSIS 23 0.0007
785 EPISTAXIS 53 0.0007
786 DIABETES MELLITUS 54 0.0007
787 MUSCULOSKELETAL PAIN 37 0.0007
788 PRESCRIBED UNDERDOSE 14 0.0007
789 CHOLELITHIASIS 23 0.0007
790 OEDEMA 38 0.0007
791 PNEUMONIA 225 0.0007
792 PULMONARY EMBOLISM 66 0.0007
793 ULCER 11 0.0007
794 RESPIRATORY TRACT INFECTION 18 0.0007
795 HOSPITALISATION 106 0.0007
796 COLITIS 26 0.0007
797 BACK PAIN 159 0.0007
798 ABDOMINAL PAIN 159 0.0007
799 MUSCULOSKELETAL DISORDER 13 0.0007
800 HOT FLUSH 51 0.0007
801 CARDIOMYOPATHY 10 0.0007
802 ACNE 51 0.0007
803 PRODUCT USE IN UNAPPROVED INDICATION 166 0.0007
804 EAR PAIN 13 0.0007
805 DYSPNOEA EXERTIONAL 25 0.0007
806 PRODUCT STORAGE ERROR 58 0.0007
807 DEVICE USE ERROR 23 0.0007
808 DEEP VEIN THROMBOSIS 43 0.0007
809 SWELLING FACE 43 0.0007
810 DYSGEUSIA 49 0.0007
811 EYE PRURITUS 22 0.0007
812 HIP FRACTURE 21 0.0007
813 PAIN 401 0.0007
814 ENCEPHALOPATHY 16 0.0007
815 HEMIPARESIS 11 0.0006
816 PREGNANCY 13 0.0006
817 PROCEDURAL PAIN 18 0.0006
818 HERPES ZOSTER 37 0.0006
819 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 116 0.0006
820 INFECTION 93 0.0006
821 EXTRA DOSE ADMINISTERED 26 0.0006
822 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
823 ADVERSE EVENT 59 0.0006
824 PYREXIA 221 0.0006
825 DRUG DOSE OMISSION BY DEVICE 50 0.0006
826 COUGH 179 0.0006
827 ALOPECIA 124 0.0006
828 PAIN IN EXTREMITY 186 0.0006
829 CARDIOVASCULAR DISORDER 16 0.0006
830 PRODUCTIVE COUGH 30 0.0006
831 TOOTH LOSS 13 0.0006
832 EYE IRRITATION 36 0.0006
833 RASH PAPULAR 14 0.0006
834 BLISTER 35 0.0006
835 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
836 HYPONATRAEMIA 35 0.0006
837 EYE PAIN 35 0.0006
838 ERUCTATION 12 0.0006
839 ERYTHEMA 127 0.0006
840 MOUTH ULCERATION 13 0.0006
841 SWELLING 57 0.0006
842 HAEMATOCRIT DECREASED 12 0.0006
843 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
844 FEBRILE NEUTROPENIA 40 0.0006
845 PAIN IN JAW 17 0.0006
846 MOBILITY DECREASED 43 0.0006
847 MENSTRUATION IRREGULAR 16 0.0006
848 CHILLS 70 0.0006
849 CYSTITIS 19 0.0006
850 RED BLOOD CELL COUNT DECREASED 17 0.0006
851 ARTHRITIS 46 0.0006
852 BURNING SENSATION 41 0.0006
853 HAEMATURIA 20 0.0006
854 INJURY 41 0.0006
855 MYALGIA 99 0.0006
856 MUSCULOSKELETAL STIFFNESS 51 0.0006
857 SKIN EXFOLIATION 49 0.0006
858 BLOOD URINE PRESENT 11 0.0006
859 ILL-DEFINED DISORDER 35 0.0006
860 ABDOMINAL DISTENSION 60 0.0006
861 CEREBRAL INFARCTION 14 0.0006
862 RASH PRURITIC 31 0.0006
863 JOINT STIFFNESS 15 0.0006
864 DYSURIA 21 0.0006
865 OXYGEN SATURATION DECREASED 32 0.0006
866 PSORIATIC ARTHROPATHY 23 0.0006
867 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
868 EYE SWELLING 21 0.0006
869 ACUTE KIDNEY INJURY 86 0.0006
870 MENORRHAGIA 11 0.0006
871 THROMBOSIS 45 0.0006
872 COLITIS ULCERATIVE 25 0.0006
873 HYPOACUSIS 24 0.0006
874 FREQUENT BOWEL MOVEMENTS 15 0.0006
875 DYSPNOEA 314 0.0006
876 DIARRHOEA 356 0.0006
877 STOMATITIS 33 0.0005
878 VISUAL ACUITY REDUCED 18 0.0005
879 DIVERTICULITIS 15 0.0005
880 FUNGAL INFECTION 18 0.0005
881 TRANSAMINASES INCREASED 12 0.0005
882 DRY SKIN 72 0.0005
883 RENAL INJURY 16 0.0005
884 LYMPHADENOPATHY 19 0.0005
885 INCORRECT DOSE ADMINISTERED BY DEVICE 14 0.0005
886 BLOOD SODIUM DECREASED 10 0.0005
887 LIVER INJURY 13 0.0005
888 HYPOKALAEMIA 24 0.0005
889 ARTHRALGIA 216 0.0005
890 PERICARDIAL EFFUSION 12 0.0005
891 MATERNAL EXPOSURE DURING PREGNANCY 46 0.0005
892 RASH MACULAR 18 0.0005
893 ABDOMINAL PAIN LOWER 13 0.0005
894 PANCREATITIS 27 0.0005
895 VAGINAL HAEMORRHAGE 22 0.0005
896 PERIPHERAL SWELLING 78 0.0005
897 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
898 INTESTINAL OBSTRUCTION 19 0.0005
899 THERAPY INTERRUPTED 36 0.0005
900 ABORTION SPONTANEOUS 20 0.0005
901 INFUSION RELATED REACTION 33 0.0005
902 RASH MACULO-PAPULAR 11 0.0005
903 UNDERDOSE 36 0.0005
904 BLOOD CREATININE INCREASED 32 0.0005
905 OSTEOPOROSIS 20 0.0005
906 RENAL FAILURE 64 0.0005
907 NEEDLE ISSUE 14 0.0005
908 LEUKOPENIA 24 0.0005
909 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
910 PRODUCT COMPLAINT 12 0.0005
911 ATRIAL FIBRILLATION 46 0.0005
912 ARTHROPATHY 26 0.0005
913 HYPERGLYCAEMIA 17 0.0005
914 FAECES DISCOLOURED 10 0.0005
915 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 21 0.0004
916 INFLUENZA LIKE ILLNESS 37 0.0004
917 SEPSIS 50 0.0004
918 CEREBRAL HAEMORRHAGE 16 0.0004
919 ABASIA 11 0.0004
920 FLATULENCE 25 0.0004
921 PNEUMONITIS 12 0.0004
922 DEVICE LEAKAGE 19 0.0004
923 MYOCARDIAL INFARCTION 76 0.0004
924 HAEMATOCHEZIA 24 0.0004
925 PREMATURE BABY 13 0.0004
926 PANCYTOPENIA 24 0.0004
927 WOUND 12 0.0004
928 ANAPHYLACTIC SHOCK 11 0.0004
929 CEREBROVASCULAR ACCIDENT 72 0.0004
930 BLOOD GLUCOSE DECREASED 20 0.0004
931 WHITE BLOOD CELL COUNT DECREASED 45 0.0004
932 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14 0.0004
933 SEPTIC SHOCK 18 0.0004
934 HYPOGLYCAEMIA 20 0.0004
935 OEDEMA PERIPHERAL 50 0.0004
936 BLOOD BILIRUBIN INCREASED 11 0.0004
937 BLOOD PRESSURE DECREASED 27 0.0004
938 RHEUMATOID ARTHRITIS 46 0.0004
939 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
940 HAEMORRHAGE 41 0.0004
941 WHEEZING 23 0.0004
942 EXPOSURE VIA SKIN CONTACT 10 0.0004
943 C-REACTIVE PROTEIN INCREASED 14 0.0004
944 NEUTROPENIA 52 0.0004
945 LABORATORY TEST ABNORMAL 11 0.0004
946 RENAL IMPAIRMENT 31 0.0004
947 IMPAIRED HEALING 12 0.0004
948 HEPATIC FAILURE 11 0.0004
949 PLASMA CELL MYELOMA 14 0.0004
950 BONE DENSITY DECREASED 11 0.0004
951 INFLAMMATION 18 0.0003
952 THROMBOCYTOPENIA 39 0.0003
953 ANAEMIA 66 0.0003
954 NEOPLASM PROGRESSION 12 0.0003
955 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
956 BONE PAIN 19 0.0003
957 SKIN BURNING SENSATION 23 0.0003
958 INJECTION SITE REACTION 22 0.0003
959 BLINDNESS 13 0.0003
960 RESPIRATORY FAILURE 23 0.0003
961 PSORIASIS 39 0.0003
962 LIVER DISORDER 13 0.0003
963 DISEASE PROGRESSION 34 0.0003
964 INJECTION SITE PRURITUS 19 0.0003
965 RENAL DISORDER 13 0.0003
966 CARDIAC DISORDER 26 0.0003
967 INJECTION SITE PAIN 85 0.0003
968 JOINT SWELLING 32 0.0003
969 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
970 INJECTION SITE BRUISING 21 0.0003
971 DEATH 226 0.0003
972 CARDIAC FAILURE 21 0.0003
973 BLOOD GLUCOSE INCREASED 49 0.0003
974 DEVICE MALFUNCTION 18 0.0003
975 PLATELET COUNT DECREASED 27 0.0003
976 CARDIAC FAILURE CONGESTIVE 20 0.0002
977 PLEURAL EFFUSION 15 0.0002
978 BREAST CANCER 22 0.0002
979 LUNG DISORDER 11 0.0002
980 INJECTION SITE SWELLING 17 0.0002
981 HAEMOGLOBIN DECREASED 22 0.0002
982 DEPENDENCE 11 0.0002
983 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
984 INJECTION SITE ERYTHEMA 23 0.0002
985 NEOPLASM MALIGNANT 11 0.0002
986 GASTROINTESTINAL HAEMORRHAGE 11 0.0001